Fate Therapeutics, Inc. , a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, today announced that the Company will host a conference call and live audio webcast on Tuesday, November 11, 2014, at 5:00 p.m. EST to report its third quarter 2014 financial results and to provide a corporate update. In order to participate in the conference call, please dial 1-877-303-6235 or 1-631-291-4837 and refer to conference ID 30822569.
http://ift.tt/1tcs91v
http://ift.tt/1tcs91v
No comments:
Post a Comment